News

Published on 14 Jan 2025 on Zacks · via Yahoo Finance

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock


Article preview image

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...

NASDAQ.BMRN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Axsome Gets FDA Nod for New Migraine Drug Symbravo, Stock Rises

The FDA approves AXSM's Symbravo for the acute treatment of migraine with or without aura in adul...

Zacks · via Yahoo Finance 1 Feb 2025

VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid...

Zacks · via Yahoo Finance 31 Jan 2025

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

BioMarin Pharmaceutical (BMRN) San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the...

Zacks · via Yahoo Finance 31 Jan 2025

MRK's sNDA for Welireg in Rare Tumors Gets FDA's Priority Tag

The FDA accepts and grants priority review to Merck's sNDA for Welireg to treat advanced...

Zacks · via Yahoo Finance 28 Jan 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 28 Jan 2025

Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 28 Jan 2025

Why Is Andreas Halvorsen Bullish On BioMarin Pharmaceutical Inc. (BMRN) Now?

We recently compiled a list of the Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks. ...

Insider Monkey · via Yahoo Finance 23 Jan 2025

Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The...

Chicago, IL – January 23, 2025 – Stocks in this week’s article are — BioMarin Pharmaceutical Inc....

Zacks · via Yahoo Finance 23 Jan 2025

J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use

JNJ's Zacks Rank & Stocks to Consider J&J currently carries a Zacks Rank #3 (Hold). Some...

Zacks · via Yahoo Finance 23 Jan 2025

Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders...

Passive investing in an index fund is a good way to ensure your own returns roughly match the...

Simply Wall St. · via Yahoo Finance 21 Jan 2025